Amersham International launches its heart imaging agent, Myoview™, in Europe gaining immediate commercial success. By 2000 global sales were more than £80 million. The chemistry for Myoview was partly developed in partnership with Cardiff University. Her Majesty The Queen is pictured at the university learning about Myoview's success.
< Previous Next >
Key:
  The Radiochemical Centre; Amersham International; Nycomed Amersham; Amersham plc
  Nycomed; Nycomed Amersham Imaging; Amersham Health
  Pharmacia; Pharmacia Biotech; Amersham Pharmacia Biotech; Amersham Biosciences
About us - Investors - Our businesses - News & events - Home

© Amersham plc 2003 - All rights reserved. Legal information